Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
about
Educational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT randomised trialNew oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney diseaseExercise-based cardiac rehabilitation for adults with atrial fibrillationVitamin K antagonist use: evidence of the difficulty of achieving and maintaining target INR range and subsequent consequencesManaging atrial fibrillation in the very elderly patient: challenges and solutionsThe Current Role of Omega-3 Fatty Acids in the Management of Atrial FibrillationThe role of action potential alternans in the initiation of atrial fibrillation in humans: a review and future directionsLeft atrial appendage exclusion-Where do we stand?Managing anticoagulation for atrial fibrillation: current issues and future strategiesSailing between Scylla and Charybdis: oral long-term anticoagulation in dialysis patientsMechanism of and therapeutic strategy for atrial fibrillation associated with diabetes mellitusRationale and current perspective for early rhythm control therapy in atrial fibrillation.Atrial fibrillation: review of current treatment strategiesAtrial arrhythmias in inherited arrhythmogenic disordersElimination Of Triggers Without An Additional Substrate Modification Is Not Sufficient In Patients With Persistent Atrial FibrillationEffect of antihypertensive agents on risk of atrial fibrillation: a meta-analysis of large-scale randomized trialsStroke Prevention in Atrial Fibrillation: Focus on Latin AmericaContinuation of dabigatran therapy in "real-world" practice in Hong KongLong-term use and cost-effectiveness of secondary prevention drugs for heart disease in Western Australian seniors (WAMACH): a study protocolImpact of transesophageal echocardiography during transseptal puncture on atrial fibrillation ablationA meta-analysis for efficacy and safety evaluation of transcatheter left atrial appendage occlusion in patients with nonvalvular atrial fibrillation.Incidence of asymptomatic oesophageal lesions after atrial fibrillation ablation using an oesophageal temperature probe with insulated thermocouples: a comparative controlled study.Impact of surround flow catheter tip irrigation in contact force ablation on the incidence of asymptomatic oesophageal lesions after atrial fibrillation ablation: a prospective comparative study.Comparison of 'anatomically designed' and 'point-by-point' catheter ablations for human atrial fibrillation in terms of procedure timing and costs in German hospitals.Left atrial pathological degeneration assessed by integrated backscatter transesophageal echocardiography as a predictor of progression to persistent atrial fibrillation: results from a prospective study of three-years follow-up.Chloroquine terminates stretch-induced atrial fibrillation more effectively than flecainide in the sheep heartPro-arrhythmogenic effects of atrial fibrillation-induced electrical remodelling: insights from the three-dimensional virtual human atriaManagement of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European Registry in Atrial Fibrillation (PREFER in AF)Cerebral microbleeds on magnetic resonance imaging and anticoagulant-associated intracerebral hemorrhage riskLong-term frequency gradients during persistent atrial fibrillation in sheep are associated with stable sources in the left atrium.Medication assessment tool to detect care issues from routine data: a pilot study in primary care.Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference.Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.Oral anticoagulation is frequently discontinued after ablation of paroxysmal atrial fibrillation despite previous stroke: data from the German Ablation Registry.Subclinical thyroid dysfunction and cognitive decline in old ageClinical, biomarker, and genetic predictors of specific types of atrial fibrillation in a community-based cohort: data of the PREVEND study.Oral Anticoagulants Initiation in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort.The safety of flecainide treatment of atrial fibrillation: long-term incidence of sudden cardiac death and proarrhythmic events.Use of event recorders and loop recorders in clinical practice: results of the European Heart Rhythm Association Survey.AF is associated with self-reported syncope and falls in a general population cohort.
P2860
Q21132512-62EAF92D-4EFD-4F56-9051-6FA23CDF9F00Q24192938-F1AC23F6-86C4-4220-A579-E48A627288EEQ24195079-46655FD2-B079-4BDF-8568-55B903CA2A01Q26746062-CA59A9A4-C0E4-40D1-826B-E7033BBE4FFFQ26775877-89473B33-8AE8-4366-85D5-BDEBD0D8D011Q26781534-17FA29DB-9F42-4167-994B-DB864ED43E33Q26822583-2E08413B-8DEB-4D2F-BC8C-79EE53740066Q26851429-592DD907-FC82-45D2-956B-D040055ABB1CQ26991728-860C4EB4-55DB-4597-A9C5-25B91B1B0875Q27006930-CA80ABB4-06FC-41AB-8122-F98B94B853DDQ27014826-113B52A5-0FC5-434A-9A06-BA515944582EQ27692632-A46CF601-218E-470C-AFF5-F0DB64016E5AQ28073181-7562AC73-8CCB-4469-AF66-9399D2E97446Q28076679-9FF9761D-45B1-44E5-B5EA-7BCAEFFB7488Q28084012-71590754-9541-4D17-ACBF-73BF7AB35E70Q28087109-B70BA914-5A86-47A8-8C39-76A46AE65953Q28359631-9A669B64-E685-4DAC-8EFA-89380128952BQ28541487-036B1AEA-02A4-4BBD-B1BB-19DFADBEA923Q28655596-975352A6-8E01-42DC-914D-444AEFC7906EQ28829803-9C15D653-C68F-433B-BD05-17D85C42EFB1Q30248612-16168C9C-3066-42C1-B4B7-38559A54F1E3Q30313925-C58029F4-E681-407D-BF2F-99D00551A10EQ30314253-D218DF6D-1116-45C8-A09D-1E98469E40ABQ30316790-1C795945-9A6A-461B-BE57-5446FF6DCD01Q30464769-849BF57A-606E-4685-8BBA-37F606188F94Q30517295-4693F6D6-0780-44D1-90F8-3263ED587178Q30545769-61A9D5CD-DA17-444E-89AE-5828B49AF6DBQ30559656-6A2AC36C-92AD-4082-BAEE-6B2EC4692144Q30570918-0239A667-82CD-47AC-B3E9-202FE83C3A3EQ30585896-7AF99286-656B-4E16-8F42-9C7D2CA7E668Q30662415-41E22B4A-36F2-4796-9230-D3FE349917D3Q30663685-6B0BC03E-2291-45A3-B5ED-1D61F5CD08E6Q30853679-0904C5BF-B8A8-4644-8966-5324833266DEQ30881747-C2E32CB4-F2F3-4C51-90AE-50870671ACD2Q31114507-192BB875-ABF3-4BFF-8CD7-8A4844114E9DQ31160340-3CE7ECF9-E0BF-4142-A491-9D956B34FF03Q31170904-C2056857-A211-4251-8B54-5AED4782E0CAQ33160108-397B2B10-902D-41CF-9E70-8BE7809267AEQ33164683-7A048011-E847-4C79-9E01-A6C887FF69C6Q33165337-B2C380EC-E763-4466-81B3-897AEA2CA29E
P2860
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Guidelines for the management ...... n Society of Cardiology (ESC).
@en
type
label
Guidelines for the management ...... n Society of Cardiology (ESC).
@en
prefLabel
Guidelines for the management ...... n Society of Cardiology (ESC).
@en
P2093
P50
P356
P1433
P1476
Guidelines for the management ...... n Society of Cardiology (ESC).
@en
P2093
A John Camm
Andreas Goette
Annalisa Angelini
Bernard Prendergast
Bulent Gorenek
ESC Committee for Practice Guidelines
Frans H Rutten
Hein Heidbuchel
Irene Savelieva
Jean-Yves Le Heuzey
P304
P356
10.1093/EUROPACE/EUQ350
P50
P577
2010-10-01T00:00:00Z